Electrocardiographic findings for predicting the left anterior descending artery chronic total occlusion in patients with inferior ST-segment elevation myocardial infarction Authors: Xiaobin Zheng, Zhaofu Zhang, Bingqi Yao, Haiyan Wu Published: 2024 ABSTRACT AbstractIn determining the culprit vessel responsible for inferior ST-segment elevation myocardial infarction (STEMI) as either the right coronary artery (RCA) or left circumflex (LCX), the electrocardiographic value has been validated. However, its ability to predict whether inferior STEMI is complicated by left anterior descending artery (LAD) chronic total occlusion remains uncertain. Based on the involvement of arteries other than the culprit vessels, 189 patients with inferior STEMI from our chest pain center were categorized into four groups: LAD occlusion group (n = 20), LAD stenosis > 50% group (n = 116), normal LAD group (n = 27), and other vessel stenosis > 50% group (n = 26). All groups underwent coronary angiography within 24 h of admission, and electrocardiogram (ECG) and clinical data were retrospectively analyzed. In the LAD occlusion group, hypertension was significantly more prevalent (P = 0.015). Although there was a trend toward higher previous cerebral infarction and lower diabetes prevalence in the Normal LAD group, neither was statistically significant (P = 0.070 and P = 0.088). The LAD occlusion group demonstrated the highest serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and the most reduced LVEF, with a higher susceptibility to cardiogenic shock (P < 0.01). This group also had a higher use of intra-aortic balloon pump (IABP) and a greater occurrence of ventricular fibrillation or tachycardia compared to the other groups (P < 0.05). The QRS duration in lead V4 (QRS V4) was 99.4 ± 19.1 ms in the LAD occlusion group, 87.5 ± 14.9 ms in the LAD stenosis group, 89.6 ± 11.4 ms in the normal LAD group, and 87.7 ± 11.7 ms in the other vessel stenosis group (P = 0.010). The difference between ST-segment depression in V4 and ST-segment elevation in lead III (ST V4↓- ST III↑) in the LAD occlusion group was the largest at -0.06 (-1.19, 1.05) mm (P = 0.029). ROC curve analysis revealed that the sensitivity of QRS V4 > 97.7ms and ST V4↓- ST III↑> 0 mm diagnosing inferior STEMI complicated with LAD occlusion was 54.5% and 50%, with a specificity of 75.1% and 78.0%, respectively. Multivariate logistic regression analysis indicated that QRS V4 (OR = 1.062, P = 0.003), ST V4↓- ST III↑ (OR = 1.641, P = 0.050), and Killip classification (OR = 2.115, P = 0.004) were all independent risk factors for LAD occlusion. In patients with inferior STEMI complicated by LAD occlusion without anterior myocardial infarction, cardiac function is poorer. The ST-segment deviation between the leads V4 and III, and the duration of QRS in the lead V4, can aid in diagnosis.Keywords: Inferior myocardial infarction, Electrocardiogram, Left anterior descending artery, ST-segmentSubject terms: Electrophysiology, Cardiology Introduction Acute inferior ST-segment elevation myocardial infarction (STEMI) is usually due to a blockage in the right coronary artery (RCA) or left circumflex (LCX), and occasionally in the left anterior descending artery (LAD), causing transmural myocardial ischemia in the inferior region of the heart1,2. This condition is the most prevalent type of acute STEMI, with an incidence rate of approximately 58.3%3. Although the incidence of nosocomial cardiogenic shock and major adverse cardiovascular events in patients with inferior STEMI is lower than in those with anterior STEMI, mortality increases with the number of involved coronary arteries4. Simultaneous inferior and anterior myocardial infarction, such as acute dual myocardial infarction, is relatively uncommon. It is typically caused by concurrent acute occlusion of both the RCA and LAD, leading to significant myocardial damage5,6. However, in clinical practice, coronary angiography frequently reveals chronic total occlusion (CTO) of the LAD in patients presenting with acute inferior STEMI, which likewise poses a threat to patient outcomes. One study demonstrated that CTO in non-infarct-related arteries (non-IRA) instead of multivessel disease (MVD) is a critical factor in increasing mortality in patients following percutaneous coronary intervention7. Furthermore, MVD with CTO, rather than MVD without CTO, is a strong predictor of cardiogenic shock incidence in patients with STEMI upon admission8. Additionally, STEMI patients with poorly developed collateral circulation in CTO lesions face significantly higher mortality and larger infarct size, whereas well-developed collaterals are associated with better survival outcomes, highlighting the adverse prognosis associated with CTO when collateral support is inadequate9,10. Given that LAD perfuses approximately 45% of the left ventricular territory and that culprit LAD involvement is associated with increased heart failure11,12, and considering the complex interaction between the CTO and IRA13, we hypothesize that chronic LAD occlusion in inferior STEMI is also related to hospital outcomes. The 12-lead electrocardiogram (ECG) is one of the most valuable clinical tools for recognizing and managing patients with acute myocardial ischemia. Previous studies have demonstrated the value of ECG in identifying the infarct-related artery (IRA) and detecting multivessel disease in inferior STEMI, especially in distinguishing RCA from LCX occlusions1,14–16. Additionally, ECG patterns linked to double ischemia from simultaneous acute occlusions of the LAD with either the RCA or LCX have also been well-documented17–19. However, these approaches have not specifically addressed the role of ECG in detecting chronic LAD occlusion within the context of acute inferior STEMI. Furthermore, while identifying LAD CTO usually relies on advanced imaging techniques like coronary computed tomography or coronary angiography, resource-limited or urgent clinical settings often demand efficient, non-invasive alternatives. This gap, along with the need for rapid and accessible diagnostics, highlights the importance of exploring ECG’s potential to detect chronic LAD occlusion without relying on advanced imaging. Building on evidence that ischemic ST-segment potentials cancel out between two opposing ischemic regions each caused by occlusion of a single artery and validated in animal models20,21, we hypothesize that in cases of inferior STEMI, ST-segment depression in lead V4 reflects reciprocal changes to ST-segment elevation in lead III. In addition, subendocardial ischemia caused by chronic LAD occlusion may further exacerbate ST-segment depression in lead V4. Moreover, localized ischemia in the anterior wall of the left ventricle may also be associated with QRS widening in lead V422. By examining the specific ECG parameters of QRS duration in lead V4 and the difference between ST-segment depression in V4 and ST-segment elevation in lead III, our study seeks to clarify the potential of these markers for recognizing chronic LAD occlusion in high-risk inferior STEMI patients. This investigation may offer practical insights for clinical settings with limited access to advanced imaging, reinforcing ECG’s role as a cost-effective and accessible diagnostic tool. Data and methods Subjects This retrospective study selected 262 patients, with 189 hospitalized at Shanxi Cardiovascular Hospital from January 2020 to June 2021, and 73 from January to March 2023. All patients presented with newly onset symptoms of acute myocardial ischemia for > 20 min, accompanied by ST-segment elevation in at least two inferior leads and elevated cardiac troponin I levels23. The exclusion criteria included patients with IRA involving the LAD, concurrent acute anterior STEMI, myocarditis, pericarditis, congenital heart disease, rheumatic heart disease, pulmonary embolism, or those on outpatient oral class I, II, or IV antiarrhythmic drugs, as well as those with preexcitation syndrome, intraventricular conduction block, chronic kidney disease, or significant electrolyte disturbances. All patients underwent percutaneous coronary intervention within 24 h of admission. Based on the involvement of the LAD, patients were classified into four groups: LAD occlusion group (LAD chronic total occlusion, n = 20), LAD stenosis > 50% group (50% < LAD obstructed < 99%, n = 116), Normal LAD group (LAD no obstruction and only IRA involved, n = 27), and Other vessel stenosis > 50% group (LAD obstructed < 50%, but with other coronary obstructed > 50% besides IRA, n = 26). The flow diagram and representative coronary angiography of the IRA (RCA or LCX) for the four groups are presented in Fig. 1A. Patients in the LAD occlusion or stenosis groups could also present with obstruction of other coronary arteries. Clinical data and in-hospital prognosis were collected from electronic databases. Smoking was defined as tobacco use within the past 12 months. Drinking was defined as consuming eight standard drinks per week (~ 14 g of alcohol per drink). Hypertension was diagnosed as systolic blood prssure (BP) ≥ 140 mmHg or diastolic BP ≥ 90 mmHg on three separate occasions or current antihypertensive treatment. Diabetes was defined as fasting glucose ≥ 7.0 mmol/L, HbA1c ≥ 6.5%, or use of antidiabetic therapy. Previous cerebral infarction was defined as a documented ischemic stroke confirmed by imaging. Cardiogenic shock was defined as systolic BP < 90 mmHg for > 30 min with end-organ hypoperfusion, requiring pharmacologic or mechanical support. The study adhered to the principles of the Helsinki Declaration and was approved by the ethics committee of Shanxi Cardiovascular Hospital. Given the retrospective nature of the study, the requirement for written informed consent was waived by the ethics committee. Flow diagram and representative coronary angiographies in the four groups (A) and the illustration of coronary artery blockage in the LAD occlusion group (B).In figure B, the RCA or LCX is the culprit vessel, and chronic LAD occlusion is identified by tapering lesions with collateral circulation. If a concurrent fresh red thrombus is present in the LAD (shown as a red block) or if there is an acute LAD occlusion, they were excluded. ST-segment elevation myocardial infarction = STEMI; RCA = right coronary artery; LCX = left circumflex coronary artery; LAD = left descending coronary artery; IRA = infarct-related artery. Definition concerning electrocardiogram The first ECG results of patients upon admission were selected for analysis. Paper speed was set at 25 mm/s, and calibration voltage at 10 mm/mV. 18-lead ECG results were recorded, and the mean duration of QRS was calculated based on three contiguous QRS complex. A line connecting the starts of adjacent QRS complex served as the horizontal baseline, and ST-segment deviation was measured at 0.04–0.06 s after the end of the QRS complex (J point). ST-segment elevation was defined as an ST-segment reaching a height of more than 1 mm above the baseline in the leads I, II, III, aVF, V5, and V6, and more than 0 mm above the baseline in the lead aVR. ST-segment depression was considered when the ST-segment was 0.5 mm lower than the baseline in the leads V4-V6. When ST-segment elevation in the inferior leads is accompanied by elevation in V3-V4 or de Winter T-wave changes in the precordial leads, the likelihood of double myocardial infarction is high and would be ruled out. In such cases, a careful coronary angiography assessment is required to evaluate the potential presence of acute lesions in two coronary arteries simultaneously19. An upright T wave was described as a T wave over 1 mm above the baseline; otherwise, it was considered flat or inverted. Echocardiography Transthoracic echocardiography was employed to assess left ventricular ejection fraction (LVEF) and valvular heart disease. LVEF was measured using the biplane modified Simpson’s method, which involves tracing the endocardial borders in apical four-chamber and two-chamber views at both end-diastole and end-systole. This technique is recognized for its precision in estimating left ventricular volumes and calculating LVEF, thereby providing an accurate reflection of systolic function24. Valvular heart disease, with a particular focus on rheumatic heart disease, was also evaluated. The severity of mitral stenosis was determined by assessing the mitral valve area (using planimetry or pressure half-time), mean transvalvular gradient, and pulmonary artery pressure. For aortic stenosis, severity was evaluated by measuring aortic valve area, transvalvular gradient, and flow velocity, in line with standard echocardiographic guidelines25. Coronary angiography Coronary angiography results were assessed by two independent observers who were blinded to the ECG findings. In this study, acute culprit lesions were identified by the presence of fresh thrombus and recent occlusion indicated by subtotal or total blockage. Acute occlusion was considered if a guidewire easily passed through the lesion or thrombus was found at the occlusion site. If no acute occlusion was found, the lesion with the most severe lumen narrowing corresponding to ST-segment elevation on the ECG was identified11. Thrombolysis in Myocardial Infarction (TIMI) flow grades were defined as: 0 for no flow, 1 for minimal flow, 2 for partial flow, and 3 for normal flow26. In the LAD CTO group, chronic total occlusion (CTO) of the LAD was defined as a complete blockage with TIMI flow grade 0 and an occlusion duration of at least three months, characterized by absence of antegrade flow and presence of well-developed collaterals. Chronic LAD occlusion was characterized by the absence of acute thrombus, lack of vessel staining at the proximal cap, and the presence of mature collaterals27. In some cases, bridging collaterals provided antegrade or retrograde flow (TIMI 0 or 1)10. LAD CTO cases were evaluated for concurrent acute thrombus formation; if the CTO segment displayed new thrombus causing at least 50% stenosis or complete occlusion, it suggested an acute event superimposed on chronic occlusion. Cases where the LAD had been chronically severely stenosed with collateral vessels and showed acute thrombus leading to 100% occlusion were classified as double culprit lesions or double myocardial infarctions, requiring careful differentiation. The ease of guidewire passage through the occlusion and the presence of LAD-related ECG changes aided in distinguishing acute LAD involvement. Challenging cases were reviewed by two experienced operators who reached a consensus, and cases confirmed as double culprit lesions or double myocardial infarctions, as well as those difficult to determine, were excluded from the study (Fig. 1B). Triple vessel disease was identified when coronary artery stenosis exceeded 50% in the LAD, RCA, and LCX. Statistical methods IBM SPSS 22.0 was employed for data analysis. First, the Shapiro-Wilk method was used to test the normality of the data. Measurement data conforming to a normal distribution were expressed as mean ± standard deviation (SD), and one-factor analysis of variance was performed for group comparisons. Measurement data with non-normal distribution were expressed as median (interquartile range), and group comparisons were conducted using the Kruskal-Wallis test. Enumeration data were expressed as rates or proportions, and group comparisons were performed using the χ² test or Fisher’s exact probability test. The ROC curve was used to determine the cut-off value, sensitivity, and specificity, while the comparison between the area under the curve (AUC) was conducted using the Z test. Indicators, including clinical features and ECG results, served as independent variables, and the occlusion of the LAD in inferior myocardial infarction was evaluated using logistic regression analysis. The goodness of fit test for the model was performed using the Hosmer-Lemeshow test. A difference with P<0.05 was considered statistically significant. Results Clinical data Of the 262 patients initially identified, 1 with a culprit LAD, 1 with end-stage renal disease, and 52 with incomplete data (due to hospital system upgrades) were excluded. Additionally, 16 patients had complete right bundle-branch block, 2 had ventricular pacing rhythms, and 1 had nonspecific intraventricular block. The final sample consisted of 189 patients for analysis. Table 1 displays comparisons of patient demographics between the four groups. The LAD occlusion group had the highest proportion of patients with hypertension (65.0%, P = 0.015) and showed a non-significant trend toward a higher prevalence of previous cerebral infarction (25.0%, P = 0.070). Diabetes prevalence tended to be lower in the Normal LAD group (P = 0.088). Serum NT-proBNP level was highest, and LVEF was lowest in the LAD occlusion group compared to the other three groups (P = 0.001, P = 0.000, respectively). The distribution of Killip classifications across the four groups showed a significant difference (P = 0.001), with more patients in Killip III and IV (cardiogenic shock) in the LAD occlusion group (P < 0.05). Specifically, cardiogenic shock was more common in the LAD occlusion group compared to the LAD stenosis (P = 0.033) and Normal LAD groups (P = 0.023), but no significant difference was observed with the Other vessel stenosis group (P = 0.228). Additionally, 5 of the 20 patients in the LAD occlusion group required intra-aortic balloon pump (IABP) support for hemodynamic stabilization, and 2 patients in the LAD occlusion group ultimately required veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and approximately one-third experienced ventricular tachycardia or fibrillation, all of which were more frequent than in the other groups (P < 0.05). Although mortality in the LAD occlusion group increased, the results were not statistically significant (P = 0.257). Table 1Comparsions of baseline demographics and in-hospital prognosis among four groups (mean ± SD, medians and interquartile range, or %).LAD occlusion(n = 20)LAD stenosis > 50%(n = 116)Normal LAD(n = 27)Other vessel stenosis (n = 26)P valueAge (y)60.65 ± 12.4062.94 ± 12.0754.04 ± 14.0655.69 ± 14.420.002Men (n,%)18 (90.0)88 (75.9)24 (88.9)23 (88.5)0.167Syptom time to admission (hours) ⁎7.00 (2.00, 9.00)7.00 (3.63, 11.75)5.00 (0.66, 7.00)3.00 (2.00, 8.00)0.348 ††Smoking (n,%)13 (65.0)62 (53.4)15 (55.6)17 (65.4)0.599Drinking (n,%)2 (10.0)17 (14.7)7 (25.9)2 (7.7)0.255Hypertension (n,%)13 (65.0)66 (56.9)7 (25.9)16 (61.5)0.015Diabetes (n,%)5 (22.6)30 (25.9)1 (3.7)5 (19.2)0.088Previous cerebral infarction (n,%)5 (25.0)14 (12.1)0 (0)3 (11.5)0.070Prior stent implation (n,% )3 (15.8)10 (8.6)3 (12.5)1 (3.8)0.524Body mass index (kg/m2)25.42 ± 2.5024.61 ± 2.9724.66 ± 2.1624.88 ± 2.360.686Heart rate (beats/min)83.00 ± 15.0975.66 ± 16.1776.11 ± 18.2873.77 ± 14.660.239SBP (mmHg)122.45 ± 23.47122.24 ± 25.86115.59 ± 16.78128.77 ± 25.580.283DBP (mmHg)79.45 ± 15.8973.75 ± 15.0774.52 ± 13.0279.23 ± 19.400.234CRP (mg/L)7.32 (3.10, 20.33)4.80 (2.35, 13.35)3.70 (2.05, 7.53)6.10 (1.03, 12.70)0.332 ††Creatinine (umol/L)71.08 ± 17.3868.05 ± 19.1468.86 ± 10.5075.36 ± 27.390.367Urea (mmol/L)6.78 ± 1.856.17 ± 2.275.7 ± 1.816.33 ± 2.760.427Sodium (mmol/L)137.80 ± 2.96136.79 ± 4.09136.23 ± 3.79136.68 ± 3.840.601Potassium (mmol/L)3.88 ± 0.474.04 ± 0.703.89 ± 0.363.88 ± 0.470.405Glucose (mmol/L)9.37 ± 3.488.22 ± 3.467.83 ± 2.207.95 ± 2.690.419CTnI (ng/ml) †50.00 (30.00, 70.00)40.20 (14.39, 60.00)31.00 (17.48, 54.00)56.00 (24.00, 70.00)0.298 ††Hs-cTnI (ng/ml) ‡21.58 (13.96, 27.02)25.61 (12.78, 27.02)18.43 (11.60, -)25.26 (5.74, 25.61)0.422 ††CK-MB at admission (U/L)86.00 (12.00, 137.80)48.00 (18.70, 107.00)74.30 (13.63, 103.25)63.00 (25.35, 135.15)0.889 ††NT-proBNP (pg/ml)2726.00 (692.00, 4016.00)776.50 (301.25, 2204.75)239.50 (112.00, 1013.75)624.00 (159.00, 2233.00)0.001LA (mm) ⁑35.8 ± 4.3235.05 ± 3.3836.33 ± 2.0836.64 ± 2.800.525LV (mm) ⁑47.00 ± 3.7446.39 ± 4.2746.33 ± 4.9348.00 ± 5.000.753LVEF (%)44.20 ± 6.1351.95 ± 7.1654.37 ± 5.3155.58 ± 6. 540.000Killip classification0.001Killip І (n,% )8 (40.0)69 (59.5)18 (66.7)17 (65.4)Killip ІI (n,% )1 (5.0)33 (28.4)6 (22.2)6 (23.1)Killip III (n,% ) §6 (30.0)6 (5.2)3 (11.1)1 (3.8)Cardiogenic shock (n,% ) §5 (25.0)8 (6.9)0 (0)2 (7.7)IABP5 (25.0)11 (9.5)0 (0)1 (3.8)0.020V-A ECMO2 (10.0)1 (0.9)0 (0)0 (0)0.016Sinus bradycardia or arrest (n, %)5 (25.0)36 (31.0)9 (33.3)7 (26.9)0.907Atrioventricular block(n, %)0.024I°4 (20.0)13 (11.2)8 (29.6)3 (11.5)II°2 (10.0)5 (4.3)4 (14.8)5 (19.2)III°2 (10.0)4 (3.4)1 (3.7)0 (0)Atrial premature or tachycardia (n, %)1 (5.0)9 (7.8)5 (18.5)0 (0)0.085Atrial fibrillation (n, %)1 (5.0)7 (6.0)0 (0)3 (11.5)0.354VT/VF (n, %)6 (30.0)10 (8.6)1 (3.7)2 (7.7)0.015Temporary pacemaker (n, %)2 (10.0)2 (1.7)0 (0)0 (0)0.065Death (n,% )2 (10.0)3 (2.6)1 (3.7)0 (0)0.257SBP = systolic blood pressure; DBP = diastolic blood pressure; CTNI = cardiac troponin I; Hs-cTNI = high-sensitivity cardiac troponin I; CK-MB = creatine kinase MB isoform; NT-proBNP = N-terminal pro-B-type natriuretic peptide; LA = left atrial diameter; LV = left ventricular diameter; LVEF = left ventricular ejection fraction; IABP = intraaortic balloon pump; V-A ECMO = veno-arterial extracorporeal membrane oxygenation; VT/VF = ventricular tachycardia/ventricular fibrillation.⁎ Measured in 63 patients.⁑ Measured in 60 patients.† Measured in 126 patients.‡ Measured in 58 patients.†† P value was determined by Kruskal-Wallis test.§ Killip III and IV comparisons across the four groups had P-values of 0.002 and 0.015, respectively. Comparsions of baseline demographics and in-hospital prognosis among four groups (mean ± SD, medians and interquartile range, or %). SBP = systolic blood pressure; DBP = diastolic blood pressure; CTNI = cardiac troponin I; Hs-cTNI = high-sensitivity cardiac troponin I; CK-MB = creatine kinase MB isoform; NT-proBNP = N-terminal pro-B-type natriuretic peptide; LA = left atrial diameter; LV = left ventricular diameter; LVEF = left ventricular ejection fraction; IABP = intraaortic balloon pump; V-A ECMO = veno-arterial extracorporeal membrane oxygenation; VT/VF = ventricular tachycardia/ventricular fibrillation. ⁎ Measured in 63 patients. ⁑ Measured in 60 patients. † Measured in 126 patients. ‡ Measured in 58 patients. †† P value was determined by Kruskal-Wallis test. § Killip III and IV comparisons across the four groups had P-values of 0.002 and 0.015, respectively. Electrocardiogram and coronary angiography A higher proportion of patients in the LAD occlusion group exhibited ST aVR↑ compared to the other three groups, while the proportions of ST V5−V6↑ and ST V7−V9↑ were lower (P < 0.05). ST depression with inverted or flat T waves in the V4, V5, and V6 leads was common in the LAD occlusion group (P = 0.027, P = 0.060, P = 0.001, respectively). In patients with inferior myocardial infarction and ST depression in the precordial leads, the sum of ST depression degrees in the V4-V6 leads in the LAD occlusion group was greater than that of the V1-V3 leads, with a percentage of about 50.0%, significantly higher than the other three groups (P < 0.01) (Table 2). Table 2Comparions of ECG parameters and coronary angiographic findings among four groups (mean ± SD or %).LAD occlusion(n = 20)LAD stenosis > 50%(n = 116)Normal LAD(n = 27)Other vessel stenosis (n = 26)P valueST aVR ↑ (n,% )12 (60.0)35 (30.2)5 (18.5)9 (34.6)0.022ST V4R ↑ (n,% )16 (80.0)67 (57.8)18 (66.7)18 (69.2)0.218ST V5−V6 ↑ (n,% )4 (20.0)45 (38.8)13 (59.3)12 (46.2)0.048ST V7−V9 ↑ (n,% )7 (35.0)74 (63.8)20 (74.1)16 (61.5)0.046ST V4 ↓ (n,% )0.027with T wave positive6 (30.0)39 (33.6)6 (22.2)8 (30.8)with T wave inversion or flat9 (45.0)22 (19.0)2 (7.4)6 (23.1)ST V5 ↓ (n,% )0.060with T wave positive6 (30.0)26 (22.4)5 (18.5)7 (26.9)with T wave inversion or flat8 (40.0)20 (17.2)2 (7.4)6 (23.1)ST V6 ↓ (n,% )0.001with T wave positive3 (15.0)17 (14.7)2 (7.4)4 (15.4)with T wave inversion or flat11 (55.0)18 (15.5)2 (7.4)5 (19.2)∑ST V4−V6 ↓ > ∑ST V1−V3 ↓10 (50.0)19 (16.4)1 (3.7)6 (23.1)0.001Cluprit lesion (n,% )0.547Proximal RCA8 (40.0)31 (26.7)6 (22.2)9 (34.6)Proximal LCX0 (0)9 (7.8)0 (0)1 (3.8)Mid-distal RCA11 (55.0)62 (53.4)18 (66.7)12 (46.2)Mid-distal LCX1 (5.0)14 (12.1)3 (11.1)4 (15.4)Proximal LAD lesion (n,% )15 (75.0)66 (56.9)0 (0)0 (0)0.000LM disease (n,% )2 (10.0)14 (12.1)0 (0)2 (7.7)0.281Triple vessel disease (n,% )13 (65.0)87 (75.0)0 (0)0 (0)0.000Right coronary dominance (n,% )19 (95.0%)106 (91.4%)25 (92.6%)26 (100%)0.459TIMI flow of IRA0.7080–115 (75.0)86 (74.1)20 (74.1)18 (69.2)24 (20.0)12 (10.3)2 (7.4)4 (15.4)31 (5.0)18 (15.5)5 (18.5)4 (15.4)TIMI flow of LAD0.0000–120 (100)0 (0)0 (0)0 (0)20 (0)3 (2.8)0 (0)0 (0)30 (0)113 (97.4)27 (100)26 (100)Collateral circulation (n,% )for IRA3 (15.0)6 (5.2)0 (0)1 (3.8)0.146for non-IRA †3 (15.0)0 (0)0 (0)2 (7.7)0.000RCA = right coronary artery; LCX = left circumflex coronary artery; LAD = left descending coronary artery; LM = left main coronary artery; TIMI = thrombolysis in myocardial infarction; IRA = infarct-related artery; ST x ↑ = ST-segment elevated in lead X; ∑ST V4−V6 ↓= sum of ST-segment depression in leads V4 – V6; ∑ST V1−V3 ↓ = sum of ST-segment depression in leads V1 – V3.† Refers to collateral circulation towards arteries other than the culprit artery and the LAD. Comparions of ECG parameters and coronary angiographic findings among four groups (mean ± SD or %). RCA = right coronary artery; LCX = left circumflex coronary artery; LAD = left descending coronary artery; LM = left main coronary artery; TIMI = thrombolysis in myocardial infarction; IRA = infarct-related artery; ST x ↑ = ST-segment elevated in lead X; ∑ST V4−V6 ↓= sum of ST-segment depression in leads V4 – V6; ∑ST V1−V3 ↓ = sum of ST-segment depression in leads V1 – V3. † Refers to collateral circulation towards arteries other than the culprit artery and the LAD. The duration of the QRS complex in the lead V4 in the LAD occlusion group was longer than that in the other three groups (LAD occlusion, 99.4 ± 19.1ms VS LAD stenosis, 87.5 ± 14.9ms VS Normal LAD 89.6 ± 11.4ms VS Other vessel stenosis, 87.7 ± 11.7ms, P = 0.010). However, there was no significant difference in QRS duration in the leads V2, II, III, and aVF between the four groups. Regarding ST deviation, the magnitude of ST depression in the lead V4 and the difference between ST depression in the lead V4 and ST elevation in the lead III (ST V4↓- ST III↑) were the largest in the LAD occlusion group (P = 0.011, P = 0.029, respectively). ST depression in the lead V2, ST elevation in the leads II, III, and aVF, ST V4↓/ST III↑, ST V4↓- ST II↑, ST V4↓- ST aVF↑, QRS V4- QRS III, and QRS V4 /QRS III were similar between the four groups (P > 0.05) (Figs. 2 and 3). Comparions of box plots of QRS complex duration in leads V2, V4, II and III among four gropus. Compared with LAD occlusion group, *P < 0.05, **P < 0.01. LAD = left descending coronary artery. Comparions of box plots of ST depressed deviation in leads V2 and V4, of ST elevated deviation in lead III, of the difference between ST depression in lead V4 and ST elevation in lead III among four gropus. Compared with LAD occlusion group, *P < 0.05, **P < 0.01. LAD = left descending coronary artery. The distribution of IRA between the four groups revealed no statistically significant differences (P >0.05). Triple vessel disease was more likely to be observed in patients with inferior STEMI complicated by LAD lesions (LAD occlusion, 65.0% VS LAD stenosis, 75.0% VS No LAD disease, 0%, P = 0.000). TIMI flow can influence clinical, ECG, and echocardiographic findings. However, no significant differences in initial TIMI flow of the IRAs were observed among the four groups (Table 2). ROC curve analysis In patients with inferior STEMI, the specificity of QRS V4 > 97.7ms and ST V4↓- ST III↑> 0 mm for predicting LAD occlusion was 75.1% and 78.0%, respectively. However, their sensitivity was lower, at 54.5% and 50%, respectively. Although combining the two indicators increased the AUC, compared with separated indicator, did not demonstrated statistical efficiency (QRS V4 VS Collaborative forecasting, P = 0.17; ST V4↓- ST III↑ VS Collaborative forecasting, P = 0.32) (Fig. 4). ROC curves of ECG variables for LAD occlusion in patients with inferior myocardial infarction. The sensitivity and specificity of QRSV4 at a cut-off value of 97.7 ms are 54.5% and 75.1%, respectively. The sensitivity and specificity of ST V4↓- ST III↑ at a cut-off value of 0 mm are 50.0% and 78.0%, respectively. When QRSV4 is collaboratived with ST V4↓- ST III↑, the Area Under Curve (AUC) improves to 0.770. LAD = left descending coronary artery; QRSV4 = QRS complex duration in lead V4; ST V4↓- ST III↑ = defference between ST depression in lead V4 and ST elevation in lead III. Logistic regression analysis Following adjustments for baseline demographic data and electrocardiogram features, logistic regression analysis revealed that QRS V4 (OR = 1.062, P = 0.003), ST V4↓- ST III↑ (OR = 1.641, P = 0.050), and Killip classification (OR = 2.115, P = 0.004) were independently associated with LAD occlusion in patients with inferior STEMI. The Hosmer-Lemeshow test indicated a well-fitting full model (χ²= 3.380, P = 0.908) (Table 3). Examples of ECGs for patients in the four groups are shown in Fig. 5. Table 3Univariate and multivariate logistic regression analysis of clinical characteristics and ECG parameters to predict LAD occlusion on admission.VariablesUnivariateP valueMultivariateP valueOR95% CIAge0.9360.274Men0.2760.296Smoking0.4240.279Diabete0.7040.824Hypertension0.2950.643Body mass index0.2510.406Heart rate0.0510.923SBP0.9630.636Creatinine0.6990.970Glucose0.1150.995CK-MB at admission0.7850.264NT-proBNP0.0290.917Killip classification0.0000.0042.1151.262~3.545ST V2 ↓deviation0.5670.966ST V4 ↓deviation0.0020.930ST II ↑deviation0.6410.888ST III ↑deviation0.5010.930ST aVF ↑deviation0.9000.946ST aVR ↑0.0080.237ST V4R ↑0.0950.139ST V5−V6 ↑0.0550.568∑ST V4−V6 ↓ > ∑ST V1−V3 ↓0.0010.477ST V4↓- ST III↑0.0030.0501.6410.999~2.694QRS V20.2490.312QRS V40.0020.0031.0621.021~1.105QRS II0.1430.232QRS III0.0240.661QRS aVF0.0500.055ST X ↓ deviation = ST-segment depressed deviation in lead X; ST X ↑ deviation = ST-segment elevated deviation in lead X; ST V4↓- ST III↑ = difference between ST depression in lead V4 and ST elevation in lead III; QRS X = QRS complex duration in lead X; CI = confidence interval; OR = odds ratio; Other abbrevations see Tables 1 and 2. Univariate and multivariate logistic regression analysis of clinical characteristics and ECG parameters to predict LAD occlusion on admission. ST X ↓ deviation = ST-segment depressed deviation in lead X; ST X ↑ deviation = ST-segment elevated deviation in lead X; ST V4↓- ST III↑ = difference between ST depression in lead V4 and ST elevation in lead III; QRS X = QRS complex duration in lead X; CI = confidence interval; OR = odds ratio; Other abbrevations see Tables 1 and 2. Examples of ECG manifestations among four different types of coronary artery involvement in patients with inferior myocadial myocardial infarction. The patient.1 is in group of “ LAD occlusion ”, the patient.2 is in group of “ LAD stenosis > 50% ”, the patient.3 is in group of “ Normal LAD ” and patient.4 is in group of “ Other vessel stenosis ”. Note that the QRSV4 and ST V4↓- ST III↑ in patient.1 are the largest. Discussion Although the role of the ECG in predicting the IRA of inferior STEMI and related theory has been elucidated, it is further proposed that QRS V4 > 97.7ms and ST V4↓- ST III↑> 0 mm can serve as indicators for predicting whether the chronic occlusion of the LAD occurs in patients experiencing inferior myocardial infarction without concomitant anterior myocardial infarction. The occlusion of LAD increases the risk of poor prognosis of the patients with inferior myocardial infarction In patients with inferior STEMI caused by acute occlusion of two-vessel coronary arteries, nearly 50% suffer from concomitant acute occlusion of the RCA and LAD, with about 32% experiencing cardiogenic shock or receiving intra-aortic balloon counterpulsation and a hospital mortality rate of 3%6. CTO accounts for approximately 8.02% of acute STEMI, and particularly for patients with STEMI complicated by cardiogenic shock, the incidence of CTO rises to 28%8. In the subjects with inferior myocardial infarction in this study, LAD CTO lesions were observed in approximately 10.6% of cases, with the IRA in 19/20 of the subjects being RCA. This finding is consistent with the natural history of coronary artery disease, meaning that compared to LCX, rapidly progressive multiple lesions are observed in LAD and RCA. This may be due to more branches and bifurcations in the proximal vessels, leading to low wall shear stress promoting atherosclerosis, as well as higher “ compression pattern ” exerted on the LAD and RCA resulting in high plaque structural stress, making the plaque more susceptible to rupture28–30. Patients with inferior STEMI experiencing CTO of LAD have a poorer prognosis as they often have chronic atherosclerotic diseases and are prone to cardiogenic shock due to low LVEF. Consequently, the ECG, with its noninvasive and convenient advantages, plays a vital role in rapidly identifying these patients with multi-vessel disease, contributing to better risk stratification and management. The significance of the ST-segment depression in the precordial leads of the patients with inferior myocardial infarction ST-segment depression in the precordial leads is often observed in ECG of inferior myocardial infarction. The possible mechanisms, in terms of imaging evaluation, include: (1) ST depression in the precordial leads represents an electrocardiographic mirror-image change corresponding to ST elevation in the inferior leads. These two ECG manifestations exhibit a strong linear correlation, and the magnitude of ST depression in the V1-V3 leads relates to the projected area of inferior ischemic myocardium in the frontal plane31,32; (2) myocardial infarction area extends from the inferior wall to adjacent sites, including the inferior septum, cardiac apex or apex septum, and posterolateral myocardium33–36; (3) concomitant anterior septal or anterolateral myocardial ischemia contribute, in part, to ST depression in patients with acute inferior STEMI37,38. Funabashi reported a case with acute inferior STEMI caused by sub-total occlusion of RCA that magnetic resonance and coronary computed tomography image fusion revealed late gadolinium enhancements and myocardial edema in the cardiac apex segment of the anterior wall, corresponding to the distal site with decreased blood supply due to the CTO of the LAD39. This report further supports the idea that non-IRA can induce “ischemia at distance”. Although it remains debatable whether ST-segment depression in the precordial leads can indicate the presence of LAD disease in patients with inferior myocardial infarction40,41, when the sum of ST depression in the left chest leads is greater than that in the right chest leads (∑ST V4−V6↓ > ∑ST V1−V3↓) or the maximum magnitude of ST depression in the precordial leads is observed in the leads V4-V6, there is a higher probability that severe stenosis of the LAD or multivessels disease occurs42–44. Roubin et al., through studying the relationship between ECG and the anatomical basis of coronary artery, found that ST depression in the anterolateral leads suggests that multiple vessel disease occurs in patients with inferior STEMI. In their study, the proportion of patients with ST depression in the leads V4-V6 (64%, 61%, and 43%, respectively) was higher than that of patients with ST depression in the leads V1-V3 (25%, 57%, and 50%, respectively)45. Hasdai et al. divided patients with inferior STEMI into three groups: in the “Maximal ST depressed in V4-V6” group, the proportion of patients with stenosis of the LAD or diagonal branch greater than 50% reached 71%. The proportion of patients with stenosis greater than 70% was significantly higher than that in the “Maximal ST depressed in V1-V3” group and the “no ST depressed” group, with proportions of 57%, 18%, and 18%, respectively43. Our results align with previous findings: the proportion of patients with ∑ST V4−V6↓ > ∑ST V1−V3↓ in the LAD occlusion group was significantly higher than that in the LAD non-occlusion group, and the magnitude of ST depression in the lead V4 was larger. However, there was no difference concerning the magnitude of ST deviation in the lead V2 and inferior leads between the LAD occlusion group and the LAD non-occlusion group in this study. Possible reasons that ST V4↓- ST III↑ could predict the occlusion of LAD in the patients with inferior myocardial infarction The reasons for selecting precordial lead V4 as an indicator of LAD occlusion are as follows: (1) ST depression in the leads V2-V3 represents an electrocardiographic mirror-image change corresponding to ST elevation in “posterior leads V7-V9” in a situation of inferior myocardial infarction accompanied by posterolateral myocardial infarction46. Occlusion of the proximal RCA leads to right ventricular infarction, which causes ST elevation in the leads V1-V3 leads47, whereas above interferences have relatively little impact on the leads V4. (2) The anatomical location of the lead V4 on the body surface is close to the cardiac apex and aligned with the left ventricular long axis or left ventricular synthetic depolarization vector, reflecting the cardiac electrical activity of the global left ventricular endocardium or cardiac apex48,49. And when LAD lesions lead to left ventricular subendocardial ischemia, the maximal magnitude of ST depression is observed in the V4 lead among the precordial leads. (3) ST variance in the lead V4 is most significant when acute occlusion occur in a single LAD or RCA22, and the proportion of ST depression in the lead V4 suffering from inferior STEMI is larger than in the other chest leads45. (4) Leads V5 and V6 often reflect electrical activities of mid-inferolateral, inferior, or apex inferior and lateral myocardium in the left ventricle47,50. Although in some cases, ST depression in the leads V5-V6 also suggests LAD disease or triple vessel disease44, for patients with inferior myocardial infarction, especially those complicated with LCX occlusion, ST elevation in the V5-V6 is observed in about 40–50% of patients, while is only 20% in the lead V451. If LCX occlusion causes ST depression in the left chest leads, the magnitude of ST depression in the V4 is larger than that in the leads V5 and V638. Based on these reasons, it is believed that the lead V4 possesses the highest sensitivity for diagnosing LAD occlusion due to its most significant ST change and stability resulting from its resistance to the influence of ischemia in other sites. Additionally, the lead V4 can effectively reflect the electrical condition of left ventricular myocardium, which further supports the study results. Similarly, the lead III reflect the cardiac electrical activity of the inferior myocardium48. The difference between ST depression in the V4 and ST elevation in the III (ST V4↓- ST III↑) can somewhat mitigate the influence of the mutual mirror change between anterior and inferior walls. In other words, ST V4↓- ST III↑ can accurately represent the ST-segment deviation of lead V4 caused by left ventricular ischemic injury after eliminating the portion of ST-segment depression resulting from the mirror-image corresponding to the ST-segment elevation of the inferior leads. This indicator can predict the occurrence of myocardial ischemia or injury in ventricular sites distant from the infarcted inferior site when occlusion of the LAD occurs, as demonstrated by the larger indicator value in the LAD occlusion group compared to the LAD non-occlusion group. Moreover, ST aVR↑ is commonly observed in the LAD occlusion group, which may suggest ischemia of the right paraseptal region or extensive ischemia of the circumferential left ventricular subendocardial myocardium, the blood supply of which is provided by the LAD52,53. The significance of the prolongation of the duration of QRS complex in the lead V4 Numerous studies support the notion that the prolongation of the QRS complex duration can predict the severity of coronary artery disease in patients with AMI54, and Yusuf et al. demonstrated that a longer QRS complex duration indicates impaired microvascular reperfusion in patients with STEMI55. It has been observed that in our patients with inferior STEMI, besides ST V4↓- ST III↑ and Killip grades, the duration of the QRS complex in the lead V4, at a cut-off value of 97.7 ms, can independently predict LAD occlusion, with a sensitivity and specificity of 54.5% and 75.1%, respectively. The possible mechanism is anterior myocardial ischemia owing to LAD occlusion developing a high potassium environment, especially around the cardiac apex, causes a deceleration of cardiomyocyte electrical conduction velocity56, primarily prolonging the duration of the QRS complex in the lead V4 rather than in other leads. Are extended ECG markers still relevant in contemporary practice? Several studies have highlighted the significance of ECG markers in managing acute coronary syndromes. For example, terminal QRS distortion has been linked to larger infarct size and reduced LVEF in inferior STEMI, indicating severe ischemia and high risk57. In anterior STEMI, ECG severity and acuteness scores (based on Anderson-Wilkins Acuteness Score) can predict myocardial damage and salvage potential, with severe, non-acute ischemia associated with the worst outcomes58. A decrease in R-wave amplitude in lead V1, combined with ST elevation in leads V7-V9, has proven useful for risk stratification in inferior STEMI, particularly within the first 4 h of onset to identify significant myocardial damage59. These findings underscore ECG’s expanding role not only in acute management but also in the development of novel, non-invasive diagnostic tools. Unlike previous studies, our research takes an innovative approach by focusing on the perspective of QRS duration in specific leads and the interactions of ST-segment changes across different leads, enhancing the practical value of ECG for identifying chronic LAD occlusion in high-risk patients with inferior STEMI, especially in resource-limited settings where advanced imaging may not be available. Automated ECG analysis via machine learning could further enhance rapid identification of high-risk patients and improve outcomes in acute care. A recent study show that machine learning significantly improves the diagnosis of occlusion myocardial infarction using ECG data, offering greater precision and sensitivity, especially in patients without classic ST-elevation60. Another study shows that novel computational features from 12-lead ECGs, combined with machine learning, can markedly improve the detection of culprit lesions in suspected acute coronary syndrome, surpassing traditional rule-based algorithms61. Despite advancements in machine learning for ECG analysis, non-invasive markers, which can be quickly and manually assessed, remain clinically essential. They provide timely, reliable insights in acute care, aiding early diagnosis and risk stratification in STEMI cases. Our focus was on refining early identification of high-risk patients in resource-limited settings where non-invasive approaches are vital. Specific ECG parameters described in this study such as the difference between ST-segment depression in lead V4 and ST-segment elevation in lead III, along with the QRS duration in lead V4, may help identify chronic LAD occlusion in inferior STEMI patients. Understanding such ECG’s paraneters is crucial for analyzing the mechanisms of ischemia at distance. And those paraneters could guide post-reperfusion management, potentially reducing the risk of pump failure and life-threatening ventricular arrhythmias after myocardial infarction. While machine learning holds promise for enhancing ECG interpretation, full clinical integration is hindered by challenges like data quality, transparency, and validation62,63. Non-invasive markers offer a stable, cost-effective alternative, particularly where machine learning may not be feasible. Recent research emphasizes the development of algorithms that utilize ECG data combined with machine learning techniques to improve diagnostic capabilities. These approaches can potentially identify subtle changes in cardiac signals that traditional methods might miss64. Thus, we advocate for a balanced diagnostic strategy that combines traditional and machine learning methods. Our research affirms the enduring clinical utility of manual ECG markers and supports further investigation into integrated models that improve diagnostic accuracy and patient outcomes in diverse settings. Limitations There are several limitations in our study. The primary limitation is the small sample size, particularly in the LAD occlusion group, which may reduce statistical power and limit generalizability to a broader population, potentially leading to type II errors. However, the study is methodologically sound and offers substantial clinical relevance, specifically highlighting potential areas for further investigation. Secondly, cardiac biomarkers (cTnI, CK-MB) were only measured at admission, despite recommendations for serial monitoring to assess myocardial damage and post-reperfusion outcomes65. Due to economic considerations, repeated measurements were restricted to high-risk patients in our hospital. Future studies should assess ECG correlations with cardiac magnetic resonance imaging (CMR)-evaluated myocardial injury. Thirdly, the ECG parameters in this research provide limited guidance for determining the optimal reperfusion strategy for LAD recanalization. In multivessel STEMI, the choice between culprit-only versus complete revascularization (immediate or staged) may affect outcomes66,67. Investigating the role of ECG in this context is essential. Finally, although collateral feeding origin and filling efficiency are linked to the ischemic area and short-term outcomes10, these factors were not evaluated in this study. Conclusions Chronic occlusion of the LAD is a significant risk factor for inferior wall myocardial infarction and is frequently associated with unfavorable in-hospital outcomes. The ST-segment difference between leads V4 and III, or the QRS duration in lead V4, may provide valuable diagnostic insights for identifying LAD impairment. Further research is needed to clarify the role of these ECG markers in guiding revascularization strategies for chronic LAD occlusion. Upcoming studies should also examine combining manually assessed ECG markers with machine learning to enhance diagnostic accuracy and support early risk stratification and management, especially in high-risk myocardial infarction scenarios. Author contributions X.Z. (Xiaobin Zheng) and Z.Z. (Zhaofu Zhang) conceived and designed the study. X.Z. performed the data collection and conducted the statistical analysis. Z.Z. and B.Y. (Bingqi Yao) contributed to the interpretation of the data. H.W. (Haiyan Wu) assisted with data collection and contributed to the manuscript preparation. X.Z. wrote the main manuscript text and prepared Figs. 1, 2 and 3. All authors reviewed and approved the final version of the manuscript.Feel free to modify the statement if needed to better reflect the specific contributions of each author. Data availability The data that support the findings of this study are available in the supplementary file. Declarations Competing interests The authors declare no competing interests. Ethics approval statement The study conforms to the Helsinki Declaration and has been approved by the Hospital Ethics Committee. Patient consent statement Since this was a retrospective study, the Ethics Committee waived the requirement for informed consent. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data that support the findings of this study are available in the supplementary file.